Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
| Website | https://leuko.com/ |
| Employees | 18 (10 on RocketReach) |
| Founded | 2017 |
| Address | 678 Massachusetts Ave, Cambridge, Massachusetts 02139, US |
| Industry | Retail, Medical Equipment Manufacturing |
| Keywords | Infection Detection, Blood Cell Analysis, Healthcare Technology, Medical Technology, Health Diagnostics, Precision Medicine, Disease Detection, Patient Monitoring, Medical Sensors, Diagnostic Tools, Health Monitoring |
| Competitors | Labcorp, Parexel, PPD, Medidata Solutions, Covance, Celerion, Veristat, Invicro, George Clinical, Lilly India +43 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular Leuko employee's phone or email?
Ian Butterworth is the Cofounder and CTO of Leuko.
10 people are employed at Leuko.
Leuko is based in Cambridge, Massachusetts.
The NAICS codes for Leuko are [33, 334].
The SIC codes for Leuko are [384, 38].